Intuitive Surgical Inc (ISRG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Intuitive Surgical Inc (ISRG) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($892.50 Million) by net assets ($17.94 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Intuitive Surgical Inc - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Intuitive Surgical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ISRG total debt and obligations for a breakdown of total debt and financial obligations.
Intuitive Surgical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intuitive Surgical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Charles Schwab Corp
NYSE:SCHW
|
0.177x |
|
Gilead Sciences Inc
NASDAQ:GILD
|
0.147x |
|
Industria de Diseno Textil SA
MC:ITX
|
0.178x |
|
Verizon Communications Inc
NYSE:VZ
|
0.106x |
|
Salesforce.com Inc
NYSE:CRM
|
0.092x |
|
Deutsche Telekom AG
XETRA:DTE
|
0.117x |
|
Deere & Company
NYSE:DE
|
-0.034x |
|
BlackRock Inc
NYSE:BLK
|
0.038x |
Annual Cash Flow Conversion Efficiency for Intuitive Surgical Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of Intuitive Surgical Inc from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see ISRG stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $17.94 Billion | $3.03 Billion | 0.169x | +15.61% |
| 2024-12-31 | $16.53 Billion | $2.42 Billion | 0.146x | +7.92% |
| 2023-12-31 | $13.40 Billion | $1.81 Billion | 0.135x | +0.92% |
| 2022-12-31 | $11.11 Billion | $1.49 Billion | 0.134x | -23.26% |
| 2021-12-31 | $11.95 Billion | $2.09 Billion | 0.175x | +14.91% |
| 2020-12-31 | $9.76 Billion | $1.48 Billion | 0.152x | -21.13% |
| 2019-12-31 | $8.28 Billion | $1.60 Billion | 0.193x | +10.30% |
| 2018-12-31 | $6.69 Billion | $1.17 Billion | 0.175x | -27.73% |
| 2017-12-31 | $4.73 Billion | $1.14 Billion | 0.242x | +34.07% |
| 2016-12-31 | $5.78 Billion | $1.04 Billion | 0.181x | +1.01% |
| 2015-12-31 | $4.32 Billion | $771.90 Million | 0.179x | -9.20% |
| 2014-12-31 | $3.38 Billion | $665.10 Million | 0.197x | -21.69% |
| 2013-12-31 | $3.50 Billion | $880.00 Million | 0.251x | +10.51% |
| 2012-12-31 | $3.58 Billion | $814.20 Million | 0.227x | -11.21% |
| 2011-12-31 | $2.65 Billion | $677.60 Million | 0.256x | -1.17% |
| 2010-12-31 | $2.04 Billion | $528.00 Million | 0.259x | +3.46% |
| 2009-12-31 | $1.54 Billion | $385.06 Million | 0.250x | +14.04% |
| 2008-12-31 | $1.27 Billion | $278.24 Million | 0.220x | -5.10% |
| 2007-12-31 | $888.67 Million | $205.69 Million | 0.231x | +36.70% |
| 2006-12-31 | $589.71 Million | $99.84 Million | 0.169x | +5.86% |
| 2005-12-31 | $442.59 Million | $70.79 Million | 0.160x | +66.15% |
| 2004-12-31 | $314.93 Million | $30.32 Million | 0.096x | +441.89% |
| 2003-12-31 | $278.96 Million | $-7.85 Million | -0.028x | +87.33% |
| 2002-12-31 | $63.68 Million | $-14.15 Million | -0.222x | +6.24% |
| 2001-12-31 | $78.29 Million | $-18.55 Million | -0.237x | -67.92% |
| 2000-12-31 | $90.73 Million | $-12.80 Million | -0.141x | +80.32% |
| 1999-12-31 | $22.21 Million | $-15.93 Million | -0.717x | -- |
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings… Read more